SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001206774-21-000305
Filing Date
2021-02-05
Accepted
2021-02-05 16:45:26
Documents
12
Period of Report
2021-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT geron3867381-8k.htm   iXBRL 8-K 37760
  Complete submission text file 0001206774-21-000305.txt   211835

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gern-20210201.xsd EX-101.SCH 3177
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20210201_pre.xml EX-101.PRE 22704
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20210201_lab.xml EX-101.LAB 34591
5 EXTRACTED XBRL INSTANCE DOCUMENT geron3867381-8k_htm.xml XML 3621
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 21596650
SIC: 2834 Pharmaceutical Preparations